Dupont Capital Management’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History
Bought
Maintained
Sold
Other funds holding OCDX
Dupont Capital Management's OCDX Position: Q2 2022 in Review
Dupont Capital Management sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 228,800 shares — an estimated $4.27M sold.
Dupont Capital Management first reported a position in OCDX in Q1 2022 and held it in 1 quarter. The position peaked at $4.27M in Q1 2022. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.
- Dupont Capital Management reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
- Dupont Capital Management sold 228,800 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $4.27M.
- Dupont Capital Management first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q1 2022 and held it in 1 quarter.
- Dupont Capital Management's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $4.27M in Q1 2022.
- 1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.
Based on Dupont Capital Management's 13F filing for Q2 2022, filed 26 Jul 2022.